Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Holding(s) in Company

13 Nov 2013 10:07

RNS Number : 9074S
Croda International PLC
13 November 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Croda International Plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

P

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

P

An event changing the breakdown of voting rights

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation: iii

BlackRock, Inc.

4. Full name of shareholder(s)

(if different from 3.): iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

8 November 2013

6. Date on which issuer notified:

12 November 2013

7. Threshold(s) that is/are crossed or

reached: vi, vii

Holding has gone above 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 10p each

 

GB0002335270

 

N/A

N/A

N/A

N/A

6,538,871

N/A

4.82%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

CFD

270,742

Nominal

Delta

 

0.20%

0.20%

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,809,613

5.02%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

BlackRock Investment Management (UK) Limited - 6,809,613 (5.02%)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

Number of Croda International Plc ordinary shares in issue, excluding shares held in treasury: 135,781,788

 

14. Contact name:

 Tom Brophy

15. Contact telephone number:

 01405 860551

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBJBMTMBMBBFJ
Date   Source Headline
18th May 20212:01 pmRNSDirector/PDMR Shareholding
11th May 20212:57 pmRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSStrategic review of PT&IC businesses
30th Apr 20213:44 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:17 amRNSDirector Declaration
14th Apr 20215:13 pmRNSDirector/PDMR Shareholding
13th Apr 20212:41 pmRNSDirector/PDMR Shareholding
12th Apr 202110:34 amRNSDirector/PDMR Shareholding
9th Apr 20215:51 pmRNSDirector/PDMR Shareholding
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
7th Apr 20217:00 amRNSCroda acquires fragrance business Parfex
6th Apr 20216:06 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
30th Mar 20215:13 pmRNSDirector/PDMR Shareholding
25th Mar 202111:11 amRNSWebinar launch Croda’s Sustainability Report 2020
25th Mar 202110:55 amRNSAnnual Financial Report
24th Mar 20213:12 pmRNSDirector/PDMR Shareholding
23rd Mar 202111:07 amRNSDirector/PDMR Shareholding
22nd Mar 202111:54 amRNSDirector/PDMR Shareholding
17th Mar 20214:37 pmRNSDirector/PDMR Shareholding
17th Mar 20214:35 pmRNSDirector/PDMR Shareholding
17th Mar 20214:32 pmRNSDirector/PDMR Shareholding
17th Mar 20214:31 pmRNSDirector/PDMR Shareholding
17th Mar 20214:30 pmRNSDirector/PDMR Shareholding
17th Mar 20214:29 pmRNSDirector/PDMR Shareholding
17th Mar 20214:28 pmRNSDirector/PDMR Shareholding
17th Mar 20214:27 pmRNSDirector/PDMR Shareholding
17th Mar 20214:23 pmRNSDirector/PDMR Shareholding
17th Mar 20214:23 pmRNSDirector/PDMR Shareholding
17th Mar 20214:22 pmRNSDirector/PDMR Shareholding
17th Mar 20214:19 pmRNSDirector/PDMR Shareholding
11th Mar 20213:25 pmRNSDirector/PDMR Shareholding
2nd Mar 20217:02 amRNSCroda acquires Alban Muller
2nd Mar 20217:00 amRNSFinal Results
11th Feb 20213:12 pmRNSDirector/PDMR Shareholding
12th Jan 20215:26 pmRNSDirector/PDMR Shareholding
30th Dec 20205:07 pmRNSDirector/PDMR Shareholding
11th Dec 20203:33 pmRNSDirector/PDMR Shareholding
30th Nov 20208:57 amRNSTotal Voting Rights
24th Nov 202012:52 pmRNSCroda completes acquisition of Iberchem
24th Nov 202010:39 amRNSDirector/PDMR Shareholding
24th Nov 202010:38 amRNSDirector/PDMR Shareholding
18th Nov 20205:30 pmRNSCroda International
18th Nov 20203:54 pmRNSResults of the Placing
18th Nov 20207:01 amRNSRetail Offer via PrimaryBid.com
18th Nov 20207:00 amRNSAcquisition of Iberchem
11th Nov 20204:50 pmRNSDirector/PDMR Shareholding
10th Nov 20201:41 pmRNSCOVID-19 vaccine contract
2nd Nov 20203:35 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.